Brokerages Set Tempus AI, Inc. (NASDAQ:TEM) PT at $68.64

Tempus AI, Inc. (NASDAQ:TEM) has been given an average recommendation of “Hold” by the fifteen ratings firms that are presently covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a sell recommendation, four have assigned a hold recommendation and nine have assigned a buy recommendation to the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $68.6429.

TEM has been the topic of several research analyst reports. Wall Street Zen upgraded shares of Tempus AI from a “sell” rating to a “hold” rating in a research report on Saturday, June 6th. HC Wainwright dropped their target price on shares of Tempus AI from $95.00 to $64.00 and set a “buy” rating on the stock in a research report on Monday, May 11th. BTIG Research reiterated a “buy” rating and issued a $80.00 target price on shares of Tempus AI in a research report on Monday, June 1st. Guggenheim dropped their target price on shares of Tempus AI from $95.00 to $60.00 and set a “buy” rating on the stock in a research report on Monday, March 30th. Finally, Stifel Nicolaus set a $60.00 target price on shares of Tempus AI in a research report on Wednesday, February 25th.

Tempus AI Stock Down 3.6%

TEM stock opened at $47.82 on Tuesday. The firm has a market cap of $8.59 billion, a PE ratio of -27.80 and a beta of 3.62. The company has a debt-to-equity ratio of 2.96, a quick ratio of 3.15 and a current ratio of 3.31. The firm’s fifty day moving average is $49.32 and its 200 day moving average is $56.82. Tempus AI has a one year low of $41.73 and a one year high of $104.32.

Tempus AI (NASDAQ:TEM) last released its quarterly earnings results on Tuesday, May 5th. The company reported ($0.13) EPS for the quarter, beating the consensus estimate of ($0.21) by $0.08. Tempus AI had a negative net margin of 22.20% and a negative return on equity of 53.83%. The company had revenue of $348.12 million for the quarter, compared to analyst estimates of $345.44 million. During the same quarter last year, the business earned ($0.24) earnings per share. The firm’s revenue was up 36.1% on a year-over-year basis. On average, research analysts forecast that Tempus AI will post -1.35 EPS for the current year.

Insiders Place Their Bets

In other news, CEO Ryan Fukushima sold 13,550 shares of Tempus AI stock in a transaction dated Tuesday, May 19th. The shares were sold at an average price of $44.07, for a total value of $597,148.50. Following the sale, the chief executive officer owned 603,558 shares in the company, valued at $26,598,801.06. This trade represents a 2.20% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, EVP Andrew Polovin sold 8,703 shares of Tempus AI stock in a transaction dated Tuesday, May 19th. The shares were sold at an average price of $44.07, for a total transaction of $383,541.21. Following the completion of the sale, the executive vice president owned 128,215 shares in the company, valued at approximately $5,650,435.05. This trade represents a 6.36% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders have sold 558,557 shares of company stock valued at $26,611,939. 24.26% of the stock is owned by company insiders.

Institutional Trading of Tempus AI

Several institutional investors have recently modified their holdings of the stock. NewEdge Advisors LLC boosted its position in Tempus AI by 1.3% during the first quarter. NewEdge Advisors LLC now owns 42,996 shares of the company’s stock worth $1,944,000 after acquiring an additional 536 shares during the last quarter. Avidity Partners Management LP acquired a new position in Tempus AI during the first quarter worth about $1,130,000. Silverback Asset Management LLC boosted its position in Tempus AI by 44.5% during the first quarter. Silverback Asset Management LLC now owns 35,700 shares of the company’s stock worth $1,614,000 after acquiring an additional 11,000 shares during the last quarter. Vestor Capital LLC boosted its position in Tempus AI by 338.2% during the first quarter. Vestor Capital LLC now owns 1,538 shares of the company’s stock worth $70,000 after acquiring an additional 1,187 shares during the last quarter. Finally, Arkadios Wealth Advisors boosted its position in Tempus AI by 9.6% during the first quarter. Arkadios Wealth Advisors now owns 4,963 shares of the company’s stock worth $224,000 after acquiring an additional 435 shares during the last quarter. Institutional investors and hedge funds own 24.22% of the company’s stock.

About Tempus AI

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.